<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04210635</url>
  </required_header>
  <id_info>
    <org_study_id>2019- A01304-53</org_study_id>
    <nct_id>NCT04210635</nct_id>
  </id_info>
  <brief_title>Management of Anxiety in Intensive Care Unit Including Olfactotherapy</brief_title>
  <acronym>OCEAN</acronym>
  <official_title>Evaluation of a Comprehensive Approach in the Management of Anxiety in Intensive Care Unit Including Olfactotherapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Laboratoires Arkopharma</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Laboratoires Arkopharma</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The OCEAN observational study is a pilot study. The aim is to validate the interest of the
      intervention of essential oils, relaxing music and dim light on the anxiety of patient who
      are in the intensive care unit.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary endpoint is a numeric scale varying from 0 (no anxiety) to 10 (anxiety maximum).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 21, 2020</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Day</target_duration>
  <primary_outcome>
    <measure>measurement of the evolution of anxiety</measure>
    <time_frame>6 hours</time_frame>
    <description>The main objective of this study is to measure the evolution of the patient's anxiety between H0 (start of a &quot;ZEN cart&quot; session) and H6 (end of the &quot;ZEN cart&quot; session).</description>
  </primary_outcome>
  <enrollment type="Anticipated">35</enrollment>
  <condition>Anxiety</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ZEN cart</intervention_name>
    <description>essential oils + relaxing music + dim light</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The target population is made up of adult patients (aged over 18) hospitalized in the
        intensive care unit and expressing a complaint or presenting a state of anxiety during
        their hospitalization.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Hospitalized in one of the departments participating in the study

          -  Presenting moderate to high intensity anxiety (Digital scale â‰¥ 5);

        Exclusion Criteria:

          -  Having already benefited from the &quot;ZEN cart&quot;

          -  Having taken an anxiolytic during the past 48 hours

          -  Patient (s) intubated and / or sedated

          -  Allergy or known intolerance to one of the essential oils used

          -  Respiratory allergies, asthma, or a history of seizures

          -  Unable to understand the information note (linguistic reason, or related to his
             medical condition)

          -  Pregnant or lactating woman.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jean-Pierre MD CIEBIERA</last_name>
    <phone>06 23 32 09 82</phone>
    <email>jeanpierreciebiera@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jessica MAGAND</last_name>
    <phone>04 83 73 33 98</phone>
    <email>jessica.magand@arkopharma.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Institut Arnault Tzanck</name>
      <address>
        <city>Saint-Laurent du Var</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Pierre Ciebiera</last_name>
      <phone>06 23 32 09 82</phone>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>December 23, 2019</study_first_submitted>
  <study_first_submitted_qc>December 23, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 26, 2019</study_first_posted>
  <last_update_submitted>July 7, 2020</last_update_submitted>
  <last_update_submitted_qc>July 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anxiety Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

